Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of alpha gpc tablet 300 mg in China. Welcome to wholesale bulk high quality alpha gpc tablet 300 mg for sale here from our factory. Good service and reasonable price are available.
Alpha GPC Tablet 300 mg is a well-formulated, highly bioavailable cholinergic nutritional supplement, with L-α-glycerophosphorylcholine as its primary active ingredient. As a physiologically endogenous phospholipid precursor naturally present in the human brain and nervous system, Alpha GPC possesses exceptional ability to efficiently cross the blood-brain barrier, delivering bioavailable choline and glycerol phosphate directly to neural tissues. This targeted delivery supports the enhanced synthesis of acetylcholine, a key neurotransmitter closely associated with cognitive processing, and facilitates the repair and regeneration of neuronal cell membrane phospholipids, thereby exerting a dual beneficial effect on neural structure and function.
Supplementation with this Alpha GPC tablet has been shown to significantly enhance multiple domains of cognitive function, including memory formation and retrieval, learning capacity, attention, focus, and executive function. Due to its reliable neuroprotective and neurotrophic properties, Alpha GPC demonstrates meaningful clinical potential in alleviating cognitive decline associated with neurodegenerative conditions such as Alzheimer's disease and vascular dementia, supporting neuronal survival and slowing the progression of cognitive impairment.
Beyond neurological benefits, Alpha GPC also contributes to the modulation of the endocrine system by stimulating growth hormone release from the anterior pituitary gland. For this reason, it is widely applied in the field of sports nutrition to support physical performance, muscle function, exercise tolerance, and post-exercise recovery.
Each tablet is manufactured to a precise standardized dosage of 300 mg, ensuring consistent dosing, improved patient compliance, and enhanced safety profile for daily use. With its dual role in supporting cognitive health and physical performance, Alpha GPC 300 mg tablets represent an ideal and evidence-based intervention that bridges the fields of neurological health and applied nutritional science.
At the same time, our company not only provides pure powders, but also tablets and injections. If needed, please feel free to contact us at any time.
Additional information of chemical compound:
|
|
|
Alpha GPC COA
Adverse reactions
Alpha GPC Tablet 300 mg (glycerophosphocholine), as a precursor drug of choline, is widely used in the fields of cognitive function improvement, motor performance enhancement, and neuroprotection due to its ability to penetrate the blood-brain barrier and promote acetylcholine synthesis. The following is a detailed description of its adverse reactions:
Classification and incidence of adverse reactions
Alpha GPC (glycerophosphocholine), as a precursor drug of choline, can be classified into two types of adverse reactions: dose-dependent reactions and individual specific reactions in its 300 mg tablet. According to clinical research and user feedback, common adverse reactions include:
Digestive system response
Nausea, vomiting, and diarrhea: The incidence rate is about 10% -15%, and it is more common when taking medication for the first time or when the dosage suddenly increases. The mechanism may be related to the overactivation of the cholinergic system leading to enhanced contraction of gastrointestinal smooth muscles.
Heartburn and abdominal discomfort: The incidence rate is about 5% -8%, which may be related to increased gastric acid secretion or gastric mucosal irritation.
Neurological response
Headache and dizziness: The incidence rate is about 12% -18%, which may be related to excessive excitation of cholinergic neurons leading to cerebral vasodilation or neurotransmitter imbalance.
Insomnia or decreased sleep quality: The incidence is about 8% -10%, especially when taken in the afternoon or evening, which may be related to the impact of elevated acetylcholine levels on the sleep center.
Confusion and fatigue: rare but severe, often seen in elderly people or patients with renal insufficiency, may be related to central nervous system inhibition caused by overactivation of the cholinergic system.
Cardiovascular system response&Allergic reaction
Hypotension and bradycardia: The incidence rate is about 3% -5%, which may be related to the stimulation of parasympathetic nerves innervated by cholinergic nerves leading to slow heart rate and vasodilation.
Withdrawal syndrome: A rare case report, characterized by tachycardia and difficulty breathing, may be related to sudden inhibition of the cholinergic system leading to autonomic nervous system dysfunction.
Rash and itching: The incidence rate is about 2% -3%, which may be related to the immune system's allergic reaction to drug ingredients.
Vascular neuroedema and dyspnea: rare but severe, requiring immediate discontinuation of medication and medical attention.
Dose effect relationship of adverse reactions
The incidence of adverse reactions in Alpha GPC Tablet 300 mg is significantly positively correlated with dosage. Clinical studies have shown that:
300 mg/day dose group:The incidence of adverse reactions is about 15% -20%, mainly mild digestive and neurological reactions.
The 600 mg/day dose group
The incidence of adverse reactions increased to 30% -35%, and the risk of serious reactions such as confusion and hypotension significantly increased.The 1200 mg/day dose group had an incidence of adverse reactions exceeding 50%, including withdrawal syndrome, severe allergic reactions, etc.
Typical case
In a double-blind randomized controlled trial targeting Alzheimer's disease patients, the incidence of dizziness was 25% in the 600 mg/day dose group, while it was only 12% in the 300 mg/day dose group.In the field of sports nutrition, it is not uncommon for athletes to take excessive doses (such as 1200 mg/time) in pursuit of increased growth hormone secretion, resulting in symptoms of cholinergic hyperactivity such as muscle tremors and bradycardia.
Individual differences and risk factors of adverse reactions
Age:
Elderly people have increased sensitivity to Alpha GPC due to decreased cholinergic system function, and the incidence of adverse reactions is 2-3 times higher than that of young people.
Renal insufficiency: Slow clearance of choline metabolites can lead to accumulation in the body, increasing the risk of hypotension, confusion, and other complications.
Genetic factors: Choline acetyltransferase (ChAT) gene polymorphism may affect an individual's metabolic efficiency towards Alpha GPC, thereby altering the risk of adverse reactions.
Drug interactions:
When used in combination with anticholinergic drugs such as atropine and benzoxetine, it may lead to decreased efficacy or increased adverse reactions due to pharmacological antagonism.
When used in combination with acetylcholinesterase inhibitors (such as donepezil and carbapenem), there may be an increased risk of cholinergic crisis due to excessive elevation of acetylcholine levels.
Mechanism analysis of adverse reactions
Central nervous system inhibition:
High dose Alpha GPC may activate M2 receptors in the central nervous system, inhibit adenylate cyclase activity, and reduce levels of cyclic adenosine monophosphate (cAMP), leading to inhibitory symptoms such as confusion and fatigue.
Overactivation of cholinergic system:
After passing through the blood-brain barrier, Alpha GPC rapidly hydrolyzes into choline and glycerophosphate. Choline, as a precursor of acetylcholine, synthesizes acetylcholine under the action of choline acetyltransferase. Excessive acetylcholine can activate muscarinic (M-type) and nicotinic (N-type) acetylcholine receptors, leading to effects such as smooth muscle contraction, vasodilation, and slowed heart rate in the gastrointestinal tract.
Immune mediated allergic reactions:
Drug components or metabolites may bind to proteins in the body as haptens, forming complete antigens and triggering IgE mediated type I hypersensitivity reactions, manifested as rash, itching, angioedema, etc.
Management strategies for adverse reactions
Dose adjustment-Initial dose optimization: It is recommended to start from 150 mg/day and gradually increase to 300 mg/day to reduce the occurrence of digestive and nervous system reactions. Elderly patients or patients with renal insufficiency are advised to adjust the dosage cautiously starting from 75 mg/day.
Individualized maintenance dose: Adjust the maintenance dose based on patient tolerance and efficacy. Patients who achieve the best therapeutic effect should maintain their highest and well tolerated dose, but avoid exceeding 600 mg/day.
Optimization of medication duration
Avoid taking in the afternoon or evening: To reduce the risk of insomnia, it is recommended to take Alpha GPC in the morning. A cross study conducted on healthy volunteers showed that taking 300 mg Alpha GPC in the morning had no significant effect on nighttime sleep quality; However, taking it in the afternoon can cause a 30 minute delay in falling asleep.
Taking with food: Taking with food can reduce the incidence of digestive system reactions such as heartburn and nausea. Clinical observations have found that co administration with high-fat foods can increase the bioavailability of Alpha GPC by 20% while reducing gastrointestinal irritation.
Monitoring and Follow up
Regular monitoring of blood pressure, heart rate, and renal function: Long term medication patients should monitor blood pressure, heart rate, and renal function indicators every 3 months to promptly detect hypotension, bradycardia, and renal function impairment.
Cognitive function assessment: Elderly patients should undergo regular cognitive function assessments to avoid serious adverse reactions such as confusion. A follow-up study on Alzheimer's disease patients showed that performing MMSE scoring every 6 months can promptly detect cognitive decline and adjust treatment plans.
Patient education
Notify the patient of possible adverse reactions and corresponding measures: Provide a detailed explanation of the adverse reactions that Alpha GPC may cause, such as heartburn, headache, insomnia, etc., and guide them to take corresponding measures, such as taking antacids for heartburn and nonsteroidal anti-inflammatory drugs for headache.
Emphasize the importance of following medical advice when taking medication: Inform patients to avoid self increasing doses or stopping medication to prevent serious adverse reactions. A clinical case showed that a patient experienced severe hypotension and confusion due to self increasing the dose to 1200 mg/day, requiring hospitalization.
Adverse reaction management for special populations
For elderly people-Half the initial dose:Elderly patients with decreased cholinergic system function have increased sensitivity to Alpha GPC. It is recommended to halve the initial dose (75-150 mg/day) and slowly titrate to the effective dose.
Closely monitor cognitive function:Elderly patients are prone to inhibitory symptoms such as confusion and fatigue, and it is necessary to closely monitor changes in cognitive function to avoid delirium or the risk of falls caused by cholinergic hyperactivity.
Pregnant and lactating women
avoid using:Animal experiments have shown that high-dose Alpha GPC may affect fetal cholinergic system development, and pregnant and lactating women should avoid using it. At present, there is no safety data for human pregnancy, and its use should be strictly avoided.
Athletes
Be alert to the risk of overdose medication:Athletes taking excessive doses of Alpha GPC (such as 1200 mg/dose) in pursuit of increased growth hormone secretion may cause serious adverse reactions such as muscle tremors, bradycardia, and withdrawal syndrome. It is recommended that athletes follow the recommended dosage range in sports medicine guidelines (≤ 600 mg/day) and avoid long-term use.
Future research directions
Long term safety research
Conduct prospective cohort studies：Conduct a prospective cohort study lasting over 5 years to evaluate the long-term effects of Alpha GPC Tablet 300 mg on cognitive function, cardiovascular system, and immune system, and provide scientific evidence for clinical medication.
Individualized medication
Develop a dose prediction model:Develop personalized dose prediction models based on ChAT gene polymorphism, renal function indicators, etc., to achieve precise medication and reduce the occurrence of adverse reactions.
Explore biomarkers:Explore the application of biomarkers such as plasma choline levels and GABA release in predicting adverse reactions, providing a basis for clinical decision-making.
Research and development of new formulations
Microencapsulation technology:Develop microencapsulated Alpha GPC formulations to control drug release rate, reduce blood drug concentration fluctuations, and lower the incidence of adverse reactions.
Transdermal patch or nasal spray:Develop non oral formulations such as transdermal patches or nasal sprays to bypass the gastrointestinal tract, reduce digestive system reactions, and improve patient tolerance.
Hot Tags: alpha gpc tablet 300 mg, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale